Christopher L. Amling

14.2k total citations
289 papers, 10.3k citations indexed

About

Christopher L. Amling is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Christopher L. Amling has authored 289 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 249 papers in Pulmonary and Respiratory Medicine, 66 papers in Oncology and 53 papers in Surgery. Recurrent topics in Christopher L. Amling's work include Prostate Cancer Diagnosis and Treatment (213 papers), Prostate Cancer Treatment and Research (198 papers) and Urologic and reproductive health conditions (47 papers). Christopher L. Amling is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (213 papers), Prostate Cancer Treatment and Research (198 papers) and Urologic and reproductive health conditions (47 papers). Christopher L. Amling collaborates with scholars based in United States, United Kingdom and Canada. Christopher L. Amling's co-authors include Christopher J. Kane, Martha K. Terris, Stephen J. Freedland, William J. Aronson, Joseph C. Presti, Horst Zincke, Judd W. Moul, Robert H. Riffenburgh, Prodromos G. Borboroglu and Matthew R. Cooperberg and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher L. Amling

283 papers receiving 10.0k citations

Peers

Countries citing papers authored by Christopher L. Amling

Since Specialization

Citations

This map shows the geographic impact of Christopher L. Amling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Amling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Amling more than expected).

Fields of papers citing papers by Christopher L. Amling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Amling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Amling. The network helps show where Christopher L. Amling may publish in the future.

Co-authorship network of co-authors of Christopher L. Amling

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Amling. A scholar is included among the top collaborators of Christopher L. Amling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Amling. Christopher L. Amling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), (unknown), Amanda M. De Hoedt, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Zachary Klaassen, Martha K. Terris, (unknown), Stephen J. Freedland, Ilona Csizmadi	0
2	A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort 2023 ·Cancer Medicine ·(unknown), Taofik Oyekunle, Zachary Klaassen, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Stephen J. Freedland	1
3	Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort 2023 ·Cancer Causes & Control ·(unknown), Lin Gu, Amanda M. De Hoedt, Matthew R. Cooperberg, Christopher L. Amling, Christopher J. Kane, Zachary Klaassen, Martha K. Terris, (unknown), Adriana C. Vidal, William J. Aronson, Stephen J. Freedland, Ilona Csizmadi	2
4	Radium-223 Utilization Patterns and Outcomes in Clinical Practice 2022 ·Urology Practice ·(unknown), (unknown), Shannon Stock, Lauren E. Howard, Amanda M. De Hoedt, Martha K. Terris, Christopher L. Amling, Christopher J. Kane, Matthew R. Cooperberg, William J. Aronson, Zachary Klaassen, Thomas J. Polascik, Adriana C. Vidal, Stephen J. Freedland	1
5	Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer 2021 ·Trials ·Kerri M. Winters‐Stone, Fuzhong Li, Fay B. Horak, Nathan F. Dieckmann, Arthur Hung, Christopher L. Amling, Tomasz M. Beer	9
6	Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Emma H. Allott, Lauren E. Howard, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Stephen J. Freedland	14
7	Predictors of Time to Metastasis in Castration-resistant Prostate Cancer 2016 ·Urology ·Daniel M. Moreira, Lauren E. Howard, (unknown), Hiruni S. Amarasekara, (unknown), (unknown), (unknown), William J. Aronson, Christopher J. Kane, Martha K. Terris, Christopher L. Amling, Matthew R. Cooperberg, (unknown), Stephen J. Freedland	56
8	Is computed tomography a necessary part of a metastatic evaluation for castration‐resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database 2015 ·Cancer ·(unknown), Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Edwin M. Posadas, Stephen J. Freedland	6
9	Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Emma H. Allott, Lauren E. Howard, Matthew R. Cooperberg, Christopher J. Kane, William J. Aronson, Martha K. Terris, Christopher L. Amling, Stephen J. Freedland	119
10	Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the S hared E qual A ccess R egional C ancer H ospital ( SEARCH ) database 2014 ·British Journal of Urology ·Emma H. Allott, Lauren E. Howard, Matthew R. Cooperberg, Christopher J. Kane, William J. Aronson, Martha K. Terris, Christopher L. Amling, Stephen J. Freedland	40
11	Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database 2013 ·Prostate Cancer and Prostatic Diseases ·Emma H. Allott, Michael R. Abern, Lukas C. Gerber, (unknown), (unknown), Martha K. Terris, (unknown), Christopher L. Amling, Matthew R. Cooperberg, Patricia G. Moorman, Stephen J. Freedland	46
12	Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients 2011 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Angela B. Smith, Mathew Raynor, Christopher L. Amling, J. Erik Busby, Erik P. Castle, Rodney Davis, Matthew E. Nielsen, Raju Thomas, Eric Wallen, Michael Woods, Raj S. Pruthi	79
13	Upgrading and Downgrading of Prostate Needle Biopsy Specimens: Risk Factors and Clinical Implications 2007 ·Urology ·Stephen J. Freedland, Christopher J. Kane, Christopher L. Amling, William J. Aronson, Martha K. Terris, Joseph C. Presti	137
14	Erectile Dysfunction and Hypogonadism among Men with HIV 2007 ·AIDS Patient Care and STDs ·Nancy F. Crum‐Cianflone, Mary Bavaro, Braden Hale, Christopher L. Amling, (unknown), Carolyn Brandt, (unknown), (unknown), Sheila Medina, Mark R. Wallace	105
15	A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management 2005 ·AIDS Patient Care and STDs ·Nancy F. Crum, (unknown), Patrick E. Olson, Christopher L. Amling, Mark R. Wallace	60
16	A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management 2005 ·AIDS Patient Care and STDs ·Nancy F. Crum, (unknown), Patrick E. Olson, Christopher L. Amling, Mark R. Wallace	5
17	Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system 2003 ·International Journal of Radiation OncologyBiologyPhysics ·Peter A.S. Johnstone, Robert H. Riffenburgh, Judd W. Moul, Leon Sun, Hongyu Wu, David G. McLeod, Christopher J. Kane, Douglas Martin, Leo Kusuda, Raymond Lance, Robert G. Douglas, Timothy F. Donahue, (unknown), (unknown), Andrew Chung, Douglas W. Soderdahl, (unknown), Christopher L. Amling	25
18	Initiation of salvage therapy for prostate cancer 2002 ·Prostate Cancer and Prostatic Diseases ·Peter A.S. Johnstone, (unknown), Robert H. Riffenburgh, Christopher L. Amling, Christopher J. Kane, Judd W. Moul	6
19	Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients 2002 ·Prostate Cancer and Prostatic Diseases ·Apurva A. Desai, Haiyan Wu, Leon Sun, Isabell A. Sesterhenn, F. K. Mostofi, D. G. R. McLeod, Christopher L. Amling, Leo Kusuda, Raymond Lance, Judi Herring, John Foley, (unknown), Jay T. Bishoff, Douglas W. Soderdahl, Judd W. Moul	30
20	URETERAL STENTING AFTER URETEROSCOPY FOR DISTAL URETERAL CALCULI: A MULTI-INSTITUTIONAL PROSPECTIVE RANDOMIZED CONTROLLED STUDY ASSESSING PAIN, OUTCOMES AND COMPLICATIONS 2001 ·The Journal of Urology ·Prodromos G. Borboroglu, Christopher L. Amling, Noah S. Schenkman, Manoj Monga, John F. Ward, (unknown), Jay T. Bishoff, Christopher J. Kane	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact